CRISPR-Cas Genome Editing in Ex Vivo Human Lungs

被引：0
|
作者：
Mesaki, K. [1 ]
Yamamoto, H. [1 ]
Juvet, S. [1 ]
Yeung, J. [2 ]
Guan, Z. [1 ]
Yao, Y. [1 ]
Chen, M. [1 ]
Gokhale, H. [1 ]
Shan, H. [1 ]
Wang, A. [1 ]
Wilson, G. [1 ]
Mariscal, A. [1 ]
Hu, J. [2 ]
Davidson, A. [2 ]
Kleinstiver, B. [3 ,4 ]
Cypel, M. [1 ]
Liu, M. [1 ]
Keshavjee, S. [1 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
8
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [1] CRISPR-Cas Genome Editing in Ex Vivo Human Lungs to Rewire the Translational Path of Genome-Targeting Therapeutics
    Mesaki, Kumi
    Yamamoto, Haruchika
    Juvet, Stephen
    Yeung, Jonathan
    Guan, Zehong
    Akhter, Akhi
    Yao, Yan
    Dickie, Cameron
    Mangat, Henna
    Wang, Aizhou
    Wilson, Gavin W.
    Mariscal, Andrea
    Hu, Jim
    Davidson, Alan R.
    Kleinstiver, Benjamin P.
    Cypel, Marcelo
    Liu, Mingyao
    Keshavjee, Shaf
    HUMAN GENE THERAPY, 2024, 35 (11-12) : 374 - 387
  • [2] Genome editing using CRISPR-Cas nucleases
    Joung, J. K.
    HUMAN GENE THERAPY, 2016, 27 (11) : A7 - A7
  • [3] Harnessing CRISPR-Cas for oomycete genome editing
    Vink, Jochem N. A.
    Hayhurst, Max
    Gerth, Monica L.
    TRENDS IN MICROBIOLOGY, 2023, 31 (09) : 947 - 958
  • [4] The CRISPR-Cas system: beyond genome editing
    Moineau, Sylvain
    Croteau, Felix R.
    Rousseau, Genevieve M.
    M S-MEDECINE SCIENCES, 2018, 34 (10): : 813 - 819
  • [5] Genome Editing in Bacteria: CRISPR-Cas and Beyond
    Arroyo-Olarte, Ruben D.
    Bravo Rodriguez, Ricardo
    Morales-Rios, Edgar
    MICROORGANISMS, 2021, 9 (04)
  • [6] In Vivo CRISPR-Cas Genome Editing with No Detectable Off-Target Mutations
    Bobbin, Maggie L.
    Akcakaya, Pinar
    Guo, Jimmy
    Fellows, Mick
    Porritt, Michelle
    Firth, Mike
    Carreras, Alba
    Baccega, Tania
    Tsai, Shengdar
    Nguyen, Nhu T.
    Seeliger, Frank
    Bjursell, Mikael
    Nitsch, Roberto
    Lopez, Jose M.
    Clement, Kendell
    Garcia, Sara P.
    Hsu, Jonathan Y.
    Pinello, Luca
    Aryee, Martin
    Mayr, Lorenz M.
    Bohlooly-Y, Mohammad
    Maresca, Marcello
    Joung, J. Keith
    MOLECULAR THERAPY, 2018, 26 (05) : 22 - 23
  • [7] Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
    Taha, Eman A.
    Lee, Joseph
    Hotta, Akitsu
    JOURNAL OF CONTROLLED RELEASE, 2022, 342 : 345 - 361
  • [8] CRISPR-Cas systems for genome editing of mammalian cells
    Mani, Indra
    Arazoe, Takayuki
    Singh, Vijai
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 15 - 30
  • [9] Simplified CRISPR-Cas genome editing for Saccharomyces cerevisiae
    Generoso, Wesley Cardoso
    Gottardi, Manuela
    Oreb, Mislay
    Boles, Eckhard
    JOURNAL OF MICROBIOLOGICAL METHODS, 2016, 127 : 203 - 205
  • [10] Harnessing CRISPR-Cas systems for bacterial genome editing
    Selle, Kurt
    Barrangou, Rodolphe
    TRENDS IN MICROBIOLOGY, 2015, 23 (04) : 225 - 232
12345